Vitamin D may not improve glucose measures in patients at risk for diabetes
Researchers observed significant improvement in LDL cholesterol in those at risk for diabetes.
Cholesterol
Statin-based therapy less effective in advanced chronic kidney disease
Statin-based therapy had a smaller effect in reducing major vascular events in patients with advanced chronic kidney disease.
Alternative non-statin therapies effectively lower LDL cholesterol
Researchers found that dietary changes, other medications, and surgery can also lower cardiovascular risk.
Lipid screening in children, adolescents: USPSTF recommendation statement
Current evidence is insufficient to weigh the balance of benefits and harms of screening.
AAP guidelines recommend screening children for high cholesterol, depression, HIV
To combat the stigma associated with selective screening, the American Academy of Pediatrics has called for all children to be screened for high cholesterol, depression, and HIV.
Few adults taking necessary cholesterol-lowering medications
A CDC team analyzed national data from 2005 through 2014 and discovered that 35% of Americans eligible to take cholesterol-lowering medication were not taking the drugs.
Sugar-sweetened drinks linked to lower HDL-C
Higher intake of sugar-sweetened beverages has been associated with lower levels of high-density lipoprotein cholesterol (HDL-C) and higher concentrations of triglycerides, according to a study published in September 2 in the Journal of Nutrition. Maria Van Rompay, PhD, and colleagues examined a multi-ethnic sample of 613 children and adolescents aged 8 years to 15…
FDA approves second nonstatin drug to treat patients with high cholesterol
The drug is approved for patients who are unable to control their LDL cholesterol with current treatment options.
Newer cholesterol guidelines better at identifying increased risk of CVD events
The 2013 ACC/AHA cholesterol management guidelines better identify the risk of CVD and presence of coronary artery disease.
FDA approves PCSK9 inhibitor for high cholesterol
The FDA approved Praluent (alirocumab), the first injectable PCSK9 inhibitor for high cholesterol.
Next post in Web Exclusives
